CVS Health Clears Low Earnings Bar, Leads S&P 500 On Return To Growth In '25

Blockhead
12 Feb

CVS Health (CVS) topped fourth-quarter earnings estimates, but still saw profit slide 38% from a year ago. However, the pharmacy chain, which has a new CEO, offered a 2025 outlook that envisions a return to growth. Though the earnings outlook is below what analysts had penciled in, it was strong enough to make CVS stock the No. 1 performing S&P…

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10